Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

The objective is to use “data, technology, and science to make self-care more precise”, with digital diagnostics ... consistently looking for health solutions that go beyond traditional ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

BARCELONA, Spain, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Grifols (MCE: GRF ... “Chronos-PD,” could accelerate the discovery of new diagnostic tools as well as the identification and development ...

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael ... The initiative, named Chronos-PD, could lead to the discovery of new ...

Spanish pharma Grifols is leveraging its massive collection ... “The hope is to accelerate and ultimately develop new diagnostics and disease-modifying therapeutics that could mitigate or ...

leading to new diagnostic tools and disease-modifying therapiesPart of broad Grifols program to find disease-revealing clues in more than 100 million proprietary plasma samples connected to real ...

The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.

in Pre-Series A funding round from Ashish Kacholia to further develop its cancer diagnostic solutions. The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs ...